Edwards Lifesciences EW Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.07B-74.4% | $4.17B+198% | $1.4B-8.0% | $1.52B+1.3% | ||
| $156.6M+0.9% | $155.2M+7.1% | $144.9M+3.8% | $139.6M+3.6% | ||
| $158.1M-2.6% | $162.3M+16.4% | $139.4M+9.9% | $126.8M+16.0% | ||
| $1.6B— | —— | $895.8M-26.5% | $1.22B-29.7% | ||
| $260.2M+3.1% | $252.4M-0.2% | $253M+3.4% | $244.6M-24.9% | ||
| $64.8M— | —— | $15.8M— | —— | ||
| -$712.9M— | —— | $173.8M— | —— | ||
| $893.4M-22.9% | $1.16B+31.8% | $879.6M-49.1% | $1.73B+237% | ||
| -$1.01B+0.2% | -$1.01B-32.6% | -$763.1M+51.8% | -$1.58B— | ||
| —— | —— | —— | -$94.8M+71.5% | ||
| $1.34B— | —— | $657.1M-32.5% | $973.6M-30.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Edwards Lifesciences generate?
- Edwards Lifesciences (EW) generated $1.4B in operating cash flow over the trailing twelve months.
- What is Edwards Lifesciences's free cash flow?
- After $269.1M of capital expenditures, Edwards Lifesciences's free cash flow was $1.1B over the trailing twelve months, up 57.5% year over year.
- Where does Edwards Lifesciences's cash flow data come from?
- Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
